268 related articles for article (PubMed ID: 12841382)
1. Immunotherapy for lymphomas.
Timmerman JM
Int J Hematol; 2003 Jun; 77(5):444-55. PubMed ID: 12841382
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic vaccine for lymphoma.
Lee ST; Neelapu SS; Kwak LW
Yonsei Med J; 2007 Feb; 48(1):1-10. PubMed ID: 17326239
[TBL] [Abstract][Full Text] [Related]
3. Current status of immunotherapy in B cell malignancies.
Kofler DM; Mayr C; Wendtner CM
Curr Drug Targets; 2006 Oct; 7(10):1371-4. PubMed ID: 17073599
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma.
Gadri Z; Kukulansky T; Bar-Or E; Haimovich J; Hollander N
J Immunother; 2009 May; 32(4):333-40. PubMed ID: 19342972
[TBL] [Abstract][Full Text] [Related]
5. The history of the development of vaccines for the treatment of lymphoma.
Timmerman JM; Levy R
Clin Lymphoma; 2000 Sep; 1(2):129-39; discussion 140. PubMed ID: 11707821
[TBL] [Abstract][Full Text] [Related]
6. Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach.
Vose JM
Hematol Oncol; 2006 Jun; 24(2):47-55. PubMed ID: 16447298
[TBL] [Abstract][Full Text] [Related]
7. Current targeted therapies in lymphomas.
Chung C
Am J Health Syst Pharm; 2019 Oct; 76(22):1825-1834. PubMed ID: 31580408
[TBL] [Abstract][Full Text] [Related]
8. Personalized immunotherapy for the treatment of non-Hodgkin lymphoma: a promising approach.
Vose J
Clin Adv Hematol Oncol; 2005 Dec; 3(12):923-32. PubMed ID: 16555434
[TBL] [Abstract][Full Text] [Related]
9. Vaccine therapy for B-cell lymphomas: next-generation strategies.
Neelapu SS; Kwak LW
Hematology Am Soc Hematol Educ Program; 2007; ():243-9. PubMed ID: 18024636
[TBL] [Abstract][Full Text] [Related]
10. T cell mediated immunotherapy for B cell lymphoma.
Schultze JL; Nadler LM
J Mol Med (Berl); 1999 Mar; 77(3):322-31. PubMed ID: 10090595
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches to the immunotherapy of B-cell malignancies: An update.
Brentjens RJ
Curr Hematol Malig Rep; 2006 Dec; 1(4):258-63. PubMed ID: 20425321
[TBL] [Abstract][Full Text] [Related]
12. Cancer immune therapy for lymphoid malignancies: recent advances.
Klausen U; Jørgensen NGD; Grauslund JH; Holmström MO; Andersen MH
Semin Immunopathol; 2019 Jan; 41(1):111-124. PubMed ID: 30006739
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
Bertinetti C; Zirlik K; Heining-Mikesch K; Ihorst G; Dierbach H; Waller CF; Veelken H
Cancer Res; 2006 Apr; 66(8):4496-502. PubMed ID: 16618777
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
15. Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
Hurvitz SA; Timmerman JM
Curr Opin Oncol; 2005 Sep; 17(5):432-40. PubMed ID: 16093791
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic strategies for the treatment of plasma cell malignancies.
Treon SP; Raje N; Anderson KC
Semin Oncol; 2000 Oct; 27(5):598-613. PubMed ID: 11049026
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
18. Biologic therapy for lymphoma.
Bendandi M; Longo DL
Curr Opin Oncol; 1999 Sep; 11(5):343-50. PubMed ID: 10505770
[TBL] [Abstract][Full Text] [Related]
19. Treatment of patients with malignant lymphomas with monoclonal antibodies.
Tesch H; Engert A; Manzke O; Diehl V; Bohlen H
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S50-3. PubMed ID: 10933189
[TBL] [Abstract][Full Text] [Related]
20. An overview of cancer immunotherapeutic strategies.
Wahid B; Ali A; Rafique S; Waqar M; Wasim M; Wahid K; Idrees M
Immunotherapy; 2018 Aug; 10(11):999-1010. PubMed ID: 30149763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
